Physician profile
Todd E Siff
NPI 1801834437
$3,015.64
in general payments reported to CMS, 2019-2025
10 companies · $21.77 in 2025
The $21.77 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.40 · 2020: $2,547 · 2021: $163 · 2023: $166 · 2024: $56.37 · 2025: $21.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $1,500.00 | 2020 | |
| Arthrex, INC. | $542.10 | 2020 | |
| Medinc of Texas | $428.46 | 2020-2024 | |
| Stryker Corporation | $181.45 | 2019-2021 | |
| Integra Lifesciences Corporation | $115.21 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Endo Pharmaceuticals INC. | $103.36 | 2019-2024 | Xiaflex |
| Depuy Synthes Sales INC. | $63.35 | 2020-2021 | |
| Alafair Biosciences, INC. | $35.31 | 2023 | Versawrap |
| Axogen | $24.63 | 2021 | |
| Endo USA, INC. | $21.77 | 2025 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Siff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.